SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (3944)3/18/1998 9:49:00 PM
From: Biomaven  Read Replies (3) | Respond to of 6136
 
There are nine abstracts from Agouron at the upcoming Am Assoc for Cancer Reaearch (AACR) conference.

A bunch of AG3340 papers, as well as AG2034 and AG337. All seems to be basic research or preclinical (nude mice) stuff.

You can access them by signing up at the site and doing a search for "Agouron" in the abstracts. Here's the link (hope it works before you have signed up):

aacr98.expocity.com

I'd post them here, but I already used up my "fair use" quota posting abstracts over on the MOGN thread. (Worth a visit by the way, to check out a potentially big conventional anticancer drug in a small company).

Peter



To: Steve Fancy who wrote (3944)3/18/1998 11:05:00 PM
From: billkirn  Respond to of 6136
 
Steve: My sense is this baby is going to keep marching up. Maybe a little overshoot to 42/43 and settle around 40 by the end of month.
If so, it will keep its upward channel going.
Thanks for keeping us informed.
Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News